Melanoma 2019: 29th Annual Cutaneous Malignancy Update


 

Intralesional Oncolytic Immunotherapy in Melanoma: Update on OPTiM Study on T-VEC for Unresectable Melanoma

50 views
August 22, 2019
0 Comments
Login to view comments. Click here to Login
Videos